v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Sales, net of returns and allowances $ 21,211 $ 7,044
Cost of sales 30,766 13,190
Gross loss (9,555) (6,146)
Operating expenses:    
Selling, general and administrative 24,722 16,047
Research and development 13,163 12,891
Impairment loss on discontinued product line investment 0 6,246
Total operating expenses 37,885 35,184
Loss from operations (47,440) (41,330)
Interest expense, net (17,421) (10,260)
Change in fair value of stock rights 1,038 0
Other (loss) income (259) 3
Loss before income taxes (64,082) (51,587)
Provision for income taxes (4) (1)
Net loss $ (64,086) $ (51,588)
Net loss per share of common stock - basic (in dollars per share) [1] $ (6.76) $ (9.43)
Net loss per share of common stock - diluted (in dollars per share) [1] $ (6.76) $ (9.43)
Weighted average shares used in computing net loss per share of common stock - basic (in shares) [1] 9,475 5,468
Weighted average shares used in computing net loss per share of common stock - diluted (in shares) [1] 9,475 5,468
[1]
*See Note 1 - Summary of Business and Significant Accounting Principles for details on the reported amounts for the year ended December 31, 2024.

Source